An enigmatic tail of CD28 signaling

Area of Science:

• Immunology
• Cellular Biology
• Molecular Signaling

Background:

• CD28 costimulation is a critical regulator of T cell responses, influencing proliferation, survival, and differentiation.
• Despite over two decades of research, the intricate mechanisms of CD28 signaling and its therapeutic potential remain areas of intense investigation.

Purpose of the Study:

• To review the signaling cascades initiated by CD28, focusing on PI-3 kinase-dependent and -independent pathways.
• To elucidate the link between CD28 signaling pathways and specific cellular outcomes in T cells.
• To highlight the implications of understanding CD28 costimulation for developing novel therapeutic strategies.

Main Methods:

• Review of existing literature on CD28 signaling pathways.
• Analysis of studies employing gene-targeted knockin mice to investigate in vivo immune responses.
• Focus on PI-3 kinase-dependent and -independent signaling cascades.

Main Results:

• CD28 costimulation governs diverse cellular processes including T cell proliferation, survival, and differentiation into specialized subsets.
• Key signaling pathways initiated by CD28, including PI-3K-dependent and -independent routes, are detailed.
• Gene-targeted knockin mouse studies have provided insights into the in vivo relevance of different CD28 signaling motifs.

Conclusions:

• Elucidating CD28 costimulation mechanisms offers significant potential for developing clinically relevant reagents.
• The development of drugs targeting CD28 ligation and signaling is an emerging therapeutic reality.
• Further research is needed to fully understand the complexities of CD28's role in immune responses.